2023 FDA Broad Agency Announcement Day Agenda
2023 FDA BAA Day
October 25, 2023, 1:00 p.m. - 4:30 p.m. EST
Agenda
All times are Eastern Standard Time. Please see the event page for additional information.
| Time | Agenda item | Presenter |
| 1:00 p.m. |
Welcome and Opening Remarks
|
Ms. Shaila Shaheed, Supervisory Program Manager, ORSI Ms. Vidya Vish, Supervisory Contract Specialist, OAGS |
| 1:10 p.m. |
FDA Funding Priorities * # Generic Drug Science & Research Priorities for FY 2024 (CDER) # Highlighted Research Areas of Interest (CDRH) # Oncology Center of Excellence and BAA Program (OCE) # BAA Overview and Priorities (OCET) # BAA Overview and Priorities (One Health) # BAA Overview and Priorities (Office of Women’s Health)
* Each presentation will be followed by a 5-minute Q&A. |
Dr. Sameer Raney (Q&A Panelist: Dr. Jessie Floura), Dr. Kimberly Maxfield Dr. Michele Lee Dr. Julie Schneider Mr. Robert Orr CAPT Brianna Skinner Dr. Joyce Obidi (Q&A Panelist: Dr. Susan Bersoff-Matcha) |
| 3:00 p.m. |
Application Process Updates # Application Updates # Overview and Required documents |
Dr. Kinnera Chada, ORSI Mr. Ian Weiss, OAGS |
| 3:30 p.m. |
Question and Answer Panel # Review of questions submitted via webinar Q&A pod, and in advance to FDABAA@fda.hhs.gov |
Panel Members: ORSI & OAGS |
| 4:25 p.m. | Adjourn and Closing Remarks | |
Note: Recording of the full event (including closed captioning and an audio transcript, presentation slides, and responses to all questions will be posted on the event page.
Acronyms
CDER - Center for Drug Evaluation and Research
CDRH - Center for Devices and Radiological Health
OAGS - Office of Acquisitions and Grants Services
OCE - Oncology Center of Excellence
OCET - Office of Counterterrorism and Emerging Threats
ORSI - Office of Regulatory Science and Innovation
OWH - Office of Women’s Health
Back to the event page